Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents
- 30 March 1999
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 41 (3), 135-144
- https://doi.org/10.1016/s0166-3542(99)00006-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995
- Antiviral therapy for human immunodeficiency virus infections.Clinical Microbiology Reviews, 1995
- Synthesis and Antiviral Activity Evaluation of Some Aminoadamantane DerivativesJournal of Medicinal Chemistry, 1994
- Mechanism of the Inhibitory Effect of Curdlan Sulfate on HIV-1 Infection in VitroVirology, 1994
- Unpacking the incoming influenza virusCell, 1992
- Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Influenza Virus Uncoating in Infected Cells and Effect of RimantadineJournal of General Virology, 1982
- Uncoating of a Rimantadine-resistant Variant of Influenza Virus in the Presence of RimantadineJournal of General Virology, 1982
- Mechanism of action of cytochalasin: evidence that it binds to actin filament ends.The Journal of cell biology, 1981